You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid-19: First lot of Russia's Sputnik V vaccine arrives in Hyderabad

'This is the 1st consignment of 150,000 doses of Sputnik-V vaccine with millions of doses to follow,' said Ministry of External Affairs.

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Agencies 

The first batch of Sputnik V vaccine arrives in Hyderabad, India. Photo: ANI
The first batch of Sputnik V vaccine arrives in Hyderabad, India. Photo: ANI

India on Saturday received the first consignment of Russia's SputnikV COVID-19 vaccine, according to the Central Board of Indirect Taxes and Customs (CBIC).

The CBIC in a tweet said that Hyderabad customs expedited the clearance of the COVID-19 vaccine imported from Russia.

"Hyderabad Customs, @cgstcushyd facilitated expeditious clearance of #SputnikV Vaccine imported from Russia, the CBIC tweeted.

Finance Minister Nirmala Sitharaman in tweet said: "Appropriate timely response @cgstcushyd. Need of the hour."

"Sputnik-V vaccine will add to India's arsenal to fight the pandemic. This third option will augment our vaccine capacity & accelerate our vaccination drive. This is the 1st consignment of 150,000 doses of Sputnik-V vaccine with millions of doses to follow," said Ministry of External Affairs. 


The government last month allowed emergency use of imported vaccines to curb the spread of infection and waived customs duty on their imports. It has also allowed citizens over the age of 18 years to receive Covid-19 vaccinations beginning May 1.

On August 11, 2020, Russia became the world's first country to register a vaccine, dubbed as SputnikV.

Following that, in September, Dr Reddy's Laboratories and Russian Direct Investment Fund (RDIF) entered into a partnership to conduct clinical trials of SputnikV, which is developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.

Dr Reddy's Laboratories has already received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine SputnikV.

Currently, India is administering two Covid vaccines. While Oxford-AstraZeneca COVID-19 vaccine Covishield is being manufactured by the Serum Institute, the indigenously developed Covaxin is being manufactured by Bharat Biotech.

India reported a record over 4.01 lakh new Covid infections and 3,523 deaths on Saturday.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, May 01 2021. 17:00 IST
RECOMMENDED FOR YOU